# A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide Gel

> **NCT00304642** · PHASE1 · COMPLETED · sponsor: **International Partnership for Microbicides, Inc.** · enrollment: 18 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** dapivirine (TMC120) vaginal gel

## Key facts

- **NCT ID:** NCT00304642
- **Lead sponsor:** International Partnership for Microbicides, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 18 (—)
- **Last updated:** 2006-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00304642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00304642, "A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide Gel". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00304642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*